by Plus Therapeutics | Apr 29, 2024 | PBC
Following our EXCITING NEWS about our $3 Million award recommendation from the United States Department of Defense, we wanted to reshare our cancer guides for Pediatric High-Grade Glioma (https://www.respect-trials.com/patient-guide-hgg/) and Ependymoma...
by Plus Therapeutics | Apr 26, 2024 | Uncategorized
Come join us at the American Association of Neurological Surgeons (AANS) Annual Meeting in Chicago, IL next week! Visit our booth to learn about our #clinicaltrials for #patients with recurrent #glioblastoma, leptomeningeal #metastases, & pediatric #braincancer...
by Plus Therapeutics | Apr 25, 2024 | Uncategorized
“Plus Therapeutics’ commitment to revolutionizing cancer treatment extends beyond this latest award. With $23 million in active awards support, the company is at the forefront of targeted radiotherapeutic research. Moreover, ongoing trials, including...
by Plus Therapeutics | Apr 24, 2024 | LM
Thank you to everyone who came by our booth at #LBBCMetsConf this last weekend! If you missed us or would like to learn more about our Leptomeningeal Metastases clinical trial for Metastatic Breast Cancer patients, you can visit our website at...
by Plus Therapeutics | Apr 23, 2024 | PBC
Exciting news yesterday as $PSTV was able to share our recent $3 Million DoD Award for our ReSPECT-PBC Pediatric Brain Cancer Trial. Stock Region Article: https://bit.ly/4b4OBXG #Nasdaq #ClinicalResearch #ClinicalTrial #PediatricOncology...
Recent Comments